Martina Becker-Schiebe1,2, Maxi Stockhammer3, Wolfgang Hoffmann4, Fabian Wetzel4, Heiko Franz3. 1. Department of Radiotherapy and Radio-Oncology, Klinikum Braunschweig, Celler Straße 38, 38114, Braunschweig, Germany. m.schiebe@klinikum-braunschweig.de. 2. Radiation Oncology, Hannover Medical School, Hannover, Germany. m.schiebe@klinikum-braunschweig.de. 3. Department of Gynecology and Obstetrics, Klinikum Braunschweig, Braunschweig, Germany. 4. Department of Radiotherapy and Radio-Oncology, Klinikum Braunschweig, Celler Straße 38, 38114, Braunschweig, Germany.
Abstract
PURPOSE: With extensive use of systemic treatment, the issue of cardiac mortality after breast cancer radiation (RT) is still important. The aim of our analysis was to clarify whether the dose to one surrogate parameter (e. g., mean heart dose, as used in most studies) reflects the dose to the other cardiovascular structures especially the left anterior descending artery depending on breathing-adapted RT. PATIENTS AND METHODS: A total of 130 patients who underwent adjuvant RT (50.4 Gy plus boost 9-16 Gy) were evaluated. In all, 71 patients were treated with free-breathing and 59 patients using respiratory monitoring (gated RT). Dosimetric associations were calculated. RESULTS: The mean dose to the heart (Dmean heart) was reduced from 2.7 (0.8-5.2) Gy to 2.4 (1.1-4.6) Gy, the Dmean LAD (left anterior descending artery) decreased from 11.1 (1.3-28.6) Gy to 9.3 (2.2-19.9) Gy with gated RT (p = 0.04). A significant relationship was shown for Dmean heart-Dmean LAD, V25heart-Dmean LAD and Dmax heart-Dmax LAD for gated patients only (p < 0.01). For every 1 Gy increase in Dmean heart, mean LAD doses rose by 3.6 Gy, without gating V25 ≤5 % did not assure a benefit and resulted in Dmean LAD between 1.3 and 28.6 Gy. CONCLUSION: A significant reduction and association of heart and coronary artery (LAD) doses using inspiratory gating was shown. However, in free-breathing plans commonly measured dose constraints do not allow precise estimation of the dose to the coronary arteries.
PURPOSE: With extensive use of systemic treatment, the issue of cardiac mortality after breast cancer radiation (RT) is still important. The aim of our analysis was to clarify whether the dose to one surrogate parameter (e. g., mean heart dose, as used in most studies) reflects the dose to the other cardiovascular structures especially the left anterior descending artery depending on breathing-adapted RT. PATIENTS AND METHODS: A total of 130 patients who underwent adjuvant RT (50.4 Gy plus boost 9-16 Gy) were evaluated. In all, 71 patients were treated with free-breathing and 59 patients using respiratory monitoring (gated RT). Dosimetric associations were calculated. RESULTS: The mean dose to the heart (Dmean heart) was reduced from 2.7 (0.8-5.2) Gy to 2.4 (1.1-4.6) Gy, the Dmean LAD (left anterior descending artery) decreased from 11.1 (1.3-28.6) Gy to 9.3 (2.2-19.9) Gy with gated RT (p = 0.04). A significant relationship was shown for Dmean heart-Dmean LAD, V25heart-Dmean LAD and Dmax heart-Dmax LAD for gated patients only (p < 0.01). For every 1 Gy increase in Dmean heart, mean LAD doses rose by 3.6 Gy, without gating V25 ≤5 % did not assure a benefit and resulted in Dmean LAD between 1.3 and 28.6 Gy. CONCLUSION: A significant reduction and association of heart and coronary artery (LAD) doses using inspiratory gating was shown. However, in free-breathing plans commonly measured dose constraints do not allow precise estimation of the dose to the coronary arteries.
Authors: M Clarke; R Collins; S Darby; C Davies; P Elphinstone; V Evans; J Godwin; R Gray; C Hicks; S James; E MacKinnon; P McGale; T McHugh; R Peto; C Taylor; Y Wang Journal: Lancet Date: 2005-12-17 Impact factor: 79.321
Authors: Suzanne B Evans; Babita Panigrahi; Veronika Northrup; Joseph Patterson; Drew E Baldwin; Susan A Higgins; Meena S Moran Journal: Pract Radiat Oncol Date: 2012-07-24
Authors: Greger Nilsson; Lars Holmberg; Hans Garmo; Olov Duvernoy; Iwar Sjögren; Bo Lagerqvist; Carl Blomqvist Journal: J Clin Oncol Date: 2011-12-27 Impact factor: 44.544
Authors: Mette H Nielsen; Martin Berg; Anders N Pedersen; Karen Andersen; Vladimir Glavicic; Erik H Jakobsen; Ingelise Jensen; Mirjana Josipovic; Ebbe L Lorenzen; Hanne M Nielsen; Lars Stenbygaard; Mette S Thomsen; Susanne Vallentin; Sune Zimmermann; Birgitte V Offersen Journal: Acta Oncol Date: 2013-02-19 Impact factor: 4.089
Authors: Candace R Correa; Indra J Das; Harold I Litt; Victor Ferrari; Wei-Ting Hwang; Lawrence J Solin; Eleanor E Harris Journal: Int J Radiat Oncol Biol Phys Date: 2008-03-12 Impact factor: 7.038
Authors: Stefanie Corradini; Hendrik Ballhausen; Helmut Weingandt; Philipp Freislederer; Stephan Schönecker; Maximilian Niyazi; Cristoforo Simonetto; Markus Eidemüller; Ute Ganswindt; Claus Belka Journal: Strahlenther Onkol Date: 2017-09-15 Impact factor: 3.621
Authors: Marc D Piroth; René Baumann; Wilfried Budach; Jürgen Dunst; Petra Feyer; Rainer Fietkau; Wulf Haase; Wolfgang Harms; Thomas Hehr; David Krug; Arnd Röser; Felix Sedlmayer; Rainer Souchon; Frederik Wenz; Rolf Sauer Journal: Strahlenther Onkol Date: 2018-10-11 Impact factor: 3.621
Authors: María Adela Poitevin-Chacón; Rubí Ramos-Prudencio; José Alfonso Rumoroso-García; Alejandro Rodríguez-Laguna; Julio Cesar Martínez-Robledo Journal: Rep Pract Oncol Radiother Date: 2019-12-19